https://www.biospace.com/aldeyra-therapeutics-receives-complete-response-letter-from-the-u-s-food-and-drug-administration-for-the-reproxalap-new-drug-application-for-the-treatment-of-dry-eye-disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for...
complete response letterfrom thetherapeuticsreceives
https://www.gsk.com/en-gb/media/press-releases/gsk-receives-complete-response-letter-from-us-fda-for-use-of-mepolizumab-in-copd-patients/
GlaxoSmithKline plc(LSE/NYSE: GSK) today received a complete response letter (CRL) from the US FDA regarding its application for mepolizumab
complete response letterus fdafor usegskreceives